Skip to Main Content

Paper Details

Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Blood Cancer J
0
2023
1 and, AICDA, BCL2, BCL2 mutations, BCL6, FL, FLs, MYC, PAX5, PIM1, RHOH, SOCS, activation-induced cytidine deaminase, cytidine, follicular lymphoma, nonsynonymous, patients, rituximab
Author NameAffiliation
Cristina CorreiaMayo Clinic
Hu LiMayo Clinic
Scott H KaufmannMayo Clinic
Scott H KaufmannMayo Clinic
Scott H KaufmannMayo Clinic
Scott H KaufmannMayo Clinic
Scott H KaufmannMayo Clinic
Scott H KaufmannMayo Clinic
  • 1 - 8

Datasets

Release 1.2